
    
      Patients (n=80) with symptomatic diabetic neuropathy will be included into this randomized
      controlled trial. Each intervention will be administered for a period of at least 30 min on
      at leat 5 days in a week. Health impairments will be assessed using the neuropathy symptom
      score (NSS) before, during and after intervention.
    
  